InvestorsHub Logo
Followers 14
Posts 565
Boards Moderated 0
Alias Born 03/01/2024

Re: None

Thursday, 07/11/2024 6:21:32 AM

Thursday, July 11, 2024 6:21:32 AM

Post# of 51102
One thing for sure...

This is setting up to have alot to talk about in the coming months.

SCI phase 2 study should be initiated
Grant applications for NIH/KRM-ll-81 is starting next month according to filing
I would think an update as to how well KRM-ll-81 did with the tier 3 NIH preclinicals would be logical
We should be due an update on ResolutionRx and the OSA program too

The EM status is obviously an unknown and the language from the company sounds truly uncertain on timing. Since they are looking for funding, have discussed reorganizing for funding channels and have an amazing pipeline of drugs heading into human clinicals, one can imagine alot of discussion and negotiation ongoing.

Either way, you cant find this kind of opportunity as a pharma investment trading at a 2 million valuation; hell you cant find it trading at 20 mil valuation. I think following this board sometimes distorts the perspective of those of us long and believing in the pipeline potential. Have to remember how positive it truly is to see stakeholders and insiders all aligning interests with the shareholders by taking equity and couple it with positive DOD funding news and now seekinig grant money for their crown jewel epilepsy and pain drug. Probably best to go enjoy the rest of summer and prepare the popcorn as this comes out the other side; hopefully transformed into that budding mid-major pharma this pipeline deserves. GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News